// App-Quantinova.ai

278 ⋆ : Ursodeoxycholic Acid is Associated with a Prolonged Transplant‐free Survival in All Patients with Primary Biliary Cholangitis ‐ there is no such thing as non‐response.

Researchers

Presenter

  • Adriaan J. van der Meer

Principal Investigators

  • Maren H. Harms

  • Christophe Corpechot

  • Douglas Thorburn

  • Willem J. Lammers

  • Pietro Invernizzi

  • Harry L. Janssen

  • Pier Maria Battezzati

  • Frederik Nevens

  • Keith D. Lindor

  • Annarosa Floreani

  • Cyriel Y. Ponsioen

  • Marlyn J. Mayo

  • Albert Pares

  • Andrew Mason

  • Kris V. Kowdley

  • Gideon M. Hirschfield

  • Henk R. van Buuren

Medical Centers

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands

  • Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom

  • Centre de Référence des Maladies Inflammatoires des VoiesBiliaires, Hôpital Saint‐Antoine, Paris, France

  • Toronto General Hospital, Toronto Centre for Liver disease, Francis Family Liver Clinic, Toronto, ON, Canada

  • Università degli Studi di Milano, Department of Health Sciences, Milan, Italy

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

  • Arizona State University, College of Health Solutions, Phoenix, AZ

  • Department of Surgery, Oncology and Gastroenterology -DiSCOG, University of Padova, Padova, Italy

  • Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, Netherlands

  • Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX

  • Liver Unit, Hospital Clinic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain

  • Gastroenterology and Liver Unit, Univeristy of Alberta, Edmonton, AB, Canada

  • Liver Care Network and Organ Care Research, Swedish Medical Center, Seattle, WA, USA

  • NIHR Biomedical Research Unit and The Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom

Locations

  • Netherlands

  • United Kingdom

  • France

  • Canada

  • Italy

  • Belgium

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary biliary cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • Ursodeoxycholic acid

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved